2015 – 2016: Member, US National Academy of Sciences/National Research Council Committee on Re-programming Non-human Populations using “Gene Drives”: Recommendations for Responsible Conduct of Research
2014 – 2015: Member, ESRC/Research Councils UK Working Group on “Antimicrobial Resistance – Setting the Social Science Agenda” and “Scoping Workshop on Antimicrobial Resistance”.
2014 – ongoing: Member, John Innes Centre Science and Impact Advisory Board.
2014 – ongoing: AcademiaNet, portal for excellent women scientists.
2014 – 2015: Member, Regenerative Medicine Expert Group, Regulation and Licensing Subgroup.
2013 – 2014: Member, Scottish Science Advisory Council Working Group on Synthetic Biology
2012 – ongoing: Member, Governance Committee, Scottish Funding Council project Industrially generated red blood cells for transfusion.
2012 – 2014: Member, TSB Stratified Medicine Public Engagement Oversight Group
2012 – ongoing: Member, Synthetic Biology Leadership Council, UK Government Department for Business Innovation and Skills.
2012 – 2014: Member, UK Department of Health Emerging Science and Bioethics Advisory Committee.
2012 – 14: Adviser to Technology Strategy Board in development of its synthetic biology Responsible Innovation Framework
2012: Participant by invitation in Road-mapping consultations organised by UK Research Councils and Technology Strategy Board on stratified medicine, synthetic biology and regenerative medicine.
Joyce has an interdisciplinary background in natural and social sciences including risk assessment and regulation, policy analysis, technology management, strategic and operational decision making in companies and public bodies. She is involved in the following Innogen projects:
Tait, J. (2012) “Innovation, Policy, and Public Interactions in the Management of Infectious Diseases”. Institute on Science for Global Policy Conference Report – Emerging and Persistent Infectious Diseases: Focus on Mitigation. Edinburgh, Oct. 23-26, 2011. Tucson Arizona, USA, www.scienceforglobalpolicy.org
Milne, C-P and Tait, J. (2009) Evolution along the Government-Governance Continuum: impacts on medicines innovation in the United States. In eds. C. Lyall, T. Papaioannou and J. Smith, Limits to Governance: challenges of policy making for the new life sciences. Aldershot: Ashgate Publishing Limited, pp 107-132.